Post market surveillance of SIMEOX, medical device to support mucociliary clearance in patients with muco-obstructive lung disease in a domiciliary setting.

Authors
Category Primary study
Registry of TrialsGerman Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: ab0af5edd5760c6697d814b64b783a772e215c41
First added on: Apr 10, 2025